Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Strong neuroprotection with a novel platinum nanoparticle against ischemic stroke- and tissue plasminogen activator-related brain damages in mice.

Takamiya M, Miyamoto Y, Yamashita T, Deguchi K, Ohta Y, Abe K.

Neuroscience. 2012 Sep 27;221:47-55. doi: 10.1016/j.neuroscience.2012.06.060. Epub 2012 Jul 3.

PMID:
22766232
2.

Neurological and pathological improvements of cerebral infarction in mice with platinum nanoparticles.

Takamiya M, Miyamoto Y, Yamashita T, Deguchi K, Ohta Y, Ikeda Y, Matsuura T, Abe K.

J Neurosci Res. 2011 Jul;89(7):1125-33. doi: 10.1002/jnr.22622. Epub 2011 Mar 23.

PMID:
21433052
3.

Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse.

Copin JC, Bengualid DJ, Da Silva RF, Kargiotis O, Schaller K, Gasche Y.

Eur J Neurosci. 2011 Oct;34(7):1085-92. doi: 10.1111/j.1460-9568.2011.07843.x. Epub 2011 Sep 6.

PMID:
21895804
4.

Protection of cerebral microvasculature after moderate hypothermia following experimental focal cerebral ischemia in mice.

Burk J, Burggraf D, Vosko M, Dichgans M, Hamann GF.

Brain Res. 2008 Aug 21;1226:248-55. doi: 10.1016/j.brainres.2008.06.015. Epub 2008 Jun 16.

PMID:
18586014
5.

Melatonin inhibits postischemic matrix metalloproteinase-9 (MMP-9) activation via dual modulation of plasminogen/plasmin system and endogenous MMP inhibitor in mice subjected to transient focal cerebral ischemia.

Tai SH, Chen HY, Lee EJ, Chen TY, Lin HW, Hung YC, Huang SY, Chen YH, Lee WT, Wu TS.

J Pineal Res. 2010 Nov;49(4):332-41. doi: 10.1111/j.1600-079X.2010.00797.x.

PMID:
20663046
6.

Intracerebral transplantation of bone marrow stromal cells ameliorates tissue plasminogen activator-induced brain damage after cerebral ischemia in mice detected by in vivo and ex vivo optical imaging.

Liu N, Deguchi K, Yamashita T, Liu W, Ikeda Y, Abe K.

J Neurosci Res. 2012 Nov;90(11):2086-93. doi: 10.1002/jnr.23104. Epub 2012 Jul 13.

PMID:
22791305
8.

Mindin is a critical mediator of ischemic brain injury in an experimental stroke model.

Wang L, Lu Y, Zhang X, Zhang Y, Jiang D, Dong X, Deng S, Yang L, Guan Y, Zhu L, Zhou Y, Zhang X, Li H.

Exp Neurol. 2013 Sep;247:506-16. doi: 10.1016/j.expneurol.2013.01.022. Epub 2013 Jan 27.

PMID:
23360804
9.

Impact of the neutrophil response to granulocyte colony-stimulating factor on the risk of hemorrhage when used in combination with tissue plasminogen activator during the acute phase of experimental stroke.

Gautier S, Ouk T, Tagzirt M, Lefebvre C, Laprais M, Pétrault O, Dupont A, Leys D, Bordet R.

J Neuroinflammation. 2014 May 27;11:96. doi: 10.1186/1742-2094-11-96.

10.

Pre-ischemic exercise reduces matrix metalloproteinase-9 expression and ameliorates blood-brain barrier dysfunction in stroke.

Guo M, Cox B, Mahale S, Davis W, Carranza A, Hayes K, Sprague S, Jimenez D, Ding Y.

Neuroscience. 2008 Jan 24;151(2):340-51. Epub 2007 Oct 18.

PMID:
18160227
11.

In vivo optical imaging correlates with improvement of cerebral ischemia treated by intravenous bone marrow stromal cells (BMSCs) and edaravone.

Tian F, Yamashita T, Deguchi K, Omote Y, Kawai H, Ohta Y, Abe K.

Neurol Res. 2013 Dec;35(10):1051-8. doi: 10.1179/1743132813Y.0000000252. Epub 2013 Aug 16.

PMID:
24070193
12.

Stachybotrys microspora triprenyl phenol-7, a novel fibrinolytic agent, suppresses superoxide production, matrix metalloproteinase-9 expression, and thereby attenuates ischemia/reperfusion injury in rat brain.

Akamatsu Y, Saito A, Fujimura M, Shimizu H, Mekawy M, Hasumi K, Tominaga T.

Neurosci Lett. 2011 Oct 3;503(2):110-4. doi: 10.1016/j.neulet.2011.08.018. Epub 2011 Aug 17.

PMID:
21871536
13.

Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia.

Tsuji K, Aoki T, Tejima E, Arai K, Lee SR, Atochin DN, Huang PL, Wang X, Montaner J, Lo EH.

Stroke. 2005 Sep;36(9):1954-9. Epub 2005 Jul 28.

14.

Effect of combined therapy with thrombolysis and citicoline in a rat model of embolic stroke.

Alonso de Leciñana M, Gutiérrez M, Roda JM, Carceller F, Díez-Tejedor E.

J Neurol Sci. 2006 Sep 25;247(2):121-9. Epub 2006 Jun 22.

PMID:
16797595
15.
16.

Reducing hemorrhagic complication by dabigatran via neurovascular protection after recanalization with tissue plasminogen activator in ischemic stroke of rat.

Kono S, Deguchi K, Omote Y, Yunoki T, Yamashita T, Kurata T, Ikeda Y, Abe K.

J Neurosci Res. 2014 Jan;92(1):46-53. doi: 10.1002/jnr.23302. Epub 2013 Nov 4.

17.

Microglial low-density lipoprotein receptor-related protein 1 mediates the effect of tissue-type plasminogen activator on matrix metalloproteinase-9 activity in the ischemic brain.

Zhang C, An J, Haile WB, Echeverry R, Strickland DK, Yepes M.

J Cereb Blood Flow Metab. 2009 Dec;29(12):1946-54. doi: 10.1038/jcbfm.2009.174. Epub 2009 Aug 12.

PMID:
19672275
18.

Bryostatin extends tPA time window to 6 h following middle cerebral artery occlusion in aged female rats.

Tan Z, Lucke-Wold BP, Logsdon AF, Turner RC, Tan C, Li X, Hongpaison J, Alkon DL, Simpkins JW, Rosen CL, Huber JD.

Eur J Pharmacol. 2015 Oct 5;764:404-12. doi: 10.1016/j.ejphar.2015.07.035. Epub 2015 Jul 17.

19.

Neuroserpin, a neuroprotective factor in focal ischemic stroke.

Cinelli P, Madani R, Tsuzuki N, Vallet P, Arras M, Zhao CN, Osterwalder T, Rülicke T, Sonderegger P.

Mol Cell Neurosci. 2001 Nov;18(5):443-57.

PMID:
11922137
20.

Laser Doppler flowmetry predicts occlusion but not tPA-mediated reperfusion success after rat embolic stroke.

Henninger N, Bouley J, Bråtane BT, Bastan B, Shea M, Fisher M.

Exp Neurol. 2009 Feb;215(2):290-7. doi: 10.1016/j.expneurol.2008.10.013. Epub 2008 Nov 7.

PMID:
19038254

Supplemental Content

Support Center